Mesoblast Limited vs IAC/Interactivecorp — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while IAC/Interactivecorp trades at $44.87 (market cap $3.32B). The key difference: IAC/Interactivecorp is the larger of the two by market cap, and IAC/Interactivecorp is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| MESO | PPLI | |
|---|---|---|
Market Cap | $2.17B | $3.32B |
Sector | Technology | Media |
52-Week High | $20.96 | $47.62 |
52-Week Low | $12.88 | $31.52 |
Enterprise Value | $2.17B | $3.63B |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →